Antibiotic Use Linked to Worse Outcomes in Patients With Gastrointestinal and Liver Cancer on Immune Checkpoint Inhibitors: A Meta-Analysis
Antibiotic use is associated with worse outcomes in patients with gastrointestinal or liver cancer receiving ICIs and should be carefully justified. Prospective studies are needed to validate these results.
Authors
- Abdelrahman M. Attia (ORCID: https://orcid.org/0000-0002-5941-9717)
- Soo Young Hwang (ORCID: https://orcid.org/0000-0001-9845-7073)
- Pin‐Jung Chen (ORCID: https://orcid.org/0000-0002-5923-5299)
- Neehar D. Parikh (ORCID: https://orcid.org/0000-0002-5874-9933)
- Pojsakorn Danpanichkul (ORCID: https://orcid.org/0000-0002-9121-165X)
- Nicole E. Rich (ORCID: https://orcid.org/0000-0003-2740-8818)
- Mohammad Saeid Rezaee-Zavareh
- Tamar Yalda
- Hamidreza Karimi-Sari
- Jun Gong
- Jessica S Liu
- Cristina R Ferrone
- Amit G. Singal
- David J. Pinato
- Osama Khattab
- Ju Dong Yang
Institutions
- Texas Tech University (US)
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- University of Maryland, Baltimore (US)
- Cedars-Sinai Medical Center (US)
- Johns Hopkins University (US)
- Rosalind Franklin University of Medicine and Science (US)
- University of Michigan (US)
- Johns Hopkins Medicine (US)
- Hammersmith Hospital (GB)
- University of Maryland Medical Center Midtown Campus (US)
- Middle East Liver Disease Center (IR)
- Imperial College London (GB)
- Tehran University of Medical Sciences (IR)
- The University of Texas Southwestern Medical Center (US)
- Texas Tech University Health Sciences Center (US)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2026-02-12
- DOI
- https://doi.org/10.14309/ajg.0000000000003956
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00